Atlas Trials

Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

RecordFirmDate
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma (NCT05169658)University of Washington2022-03-23
Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma (NCT02339922)University of Washington2016-05-19
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas (NCT02332980)Mayo Clinic2015-02-19

Track Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue automatically

Every clearance here is in the API, with alerts when new ones post.